Evidence map›Paper›PMID 20231455›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2010

Targeted deletion of betaIII spectrin impairs synaptogenesis and generates ataxic and seizure phenotypes.

Michael C Stankewich, Babette Gwynn, Thomas Ardito, Lan Ji, Jung Kim, Raymond F Robledo, Samuel E Lux, Luanne L Peters, Jon S Morrow

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  11. Ankyrin-R Links Kv3.3 to the Spectrin Cytoskeleton and Is Required for Purkinje Neuron Survival.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  12. Article
  13. The role of the membrane-associated periodic skeleton in axons.Cellular and molecular life sciences : CMLS · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Michael C StankewichDepartment of Pathology, Yale University, New Haven, CT 06520, USA.
Babette Gwynn
Thomas Ardito
Lan Ji
Jung Kim
Raymond F Robledo
Samuel E Lux
Luanne L Peters
Jon S Morrow
Jackson Laboratory · USBoston Children's Hospital · USYale University · US

Funding

MEMBRANE SKELETAL CONTROL IN HEMOLYTIC DISORDERSR01HL028560 · NHLBI · YALE UNIVERSITY · PI MORROW, JON S · 1985 to 2011
$3.3M
Topographic Spectrin Assembly in the Renal Tubule CellR01DK043812 · NIDDK · YALE UNIVERSITY · PI MORROW, JON S · 1991 to 2007
$1.9M
Genetic Identification of Novel Genes Critical in ErythropoiesisR01HL088468 · NHLBI · NEW YORK BLOOD CENTER · PI PETERS, LUANNE L · 2008 to 2011
$1.7M
NHLBI NIH HHS R01 HL028560NHLBI NIH HHS R01 HL088468NHLBI NIH HHS R01-HL088468NHLBI NIH HHS R01-HL28560NIDDK NIH HHS R01 DK043812NIDDK NIH HHS R01-DK43812
6 · The paper itself

Abstract

The spectrin membrane skeleton controls the disposition of selected membrane channels, receptors, and transporters. In the brain betaIII spectrin binds directly to the excitatory amino acid transporter (EAAT4), the glutamate receptor delta, and other proteins. Mutations in betaIII spectrin link strongly to human spinocerebellar ataxia type 5 (SCA5), correlating with alterations in EAAT4. We have explored the mechanistic basis of this phenotype by targeted gene disruption of Spnb3. Mice lacking intact betaIII spectrin develop normally. By 6 months they display a mild nonprogressive ataxia. By 1 year most Spnb3(-/-) animals develop a myoclonic seizure disorder with significant reductions of EAAT4, EAAT1, GluRdelta, IP3R, and NCAM140. Other synaptic proteins are normal. The cerebellum displays increased dark Purkinje cells (PC), a thin molecular layer, fewer synapses, a loss of dendritic spines, and a 2-fold expansion of the PC dendrite diameter. Membrane and expanded Golgi profiles fill the PC dendrite and soma, and both regions accumulate EAAT4. Correlating with the seizure disorder are enhanced hippocampal levels of neuropeptide Y and EAAT3 and increased calpain proteolysis of alphaII spectrin. It appears that betaIII spectrin disruption impairs synaptogenesis by disturbing the intracellular pathways selectively regulating protein trafficking to the synapse. The mislocalization of these proteins secondarily disrupts glutamate transport dynamics, leading to seizures, neuronal damage, and compensatory changes in EAAT3 and neuropeptide Y.

Indexed as

AnimalsAtaxiaBase SequenceBrainDisease Models, AnimalDNA PrimersExcitatory Amino Acid Transporter 4FemaleGene TargetingHumansMaleMiceMice, Inbred C57BLMice, KnockoutMicroscopy, Electron, TransmissionNerve DegenerationDNA PrimersExcitatory Amino Acid Transporter 4Slc1a6 protein, mouseSpectrin

Identifiers

PMID20231455
PMCPMC2851889
OpenAlexW2122067690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.